These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11111354)

  • 1. Strategies to improve compensation for pharmaceutical care services.
    Bennett MS; Blank D; Bopp J; James JA; Osterhaus MC
    J Am Pharm Assoc (Wash); 2000; 40(6):747-55. PubMed ID: 11111354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Billing third party payers for pharmaceutical care services.
    Poirier S; Buffington DE; Memoli GA
    J Am Pharm Assoc (Wash); 1999; 39(1):50-64; quiz 101-2. PubMed ID: 9990188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic terminology in obtaining reimbursement for pharmacists' cognitive services.
    Nutescu EA; Klotz RS
    Am J Health Syst Pharm; 2007 Jan; 64(2):186-92. PubMed ID: 17215470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacist compensation for ambulatory patient care services.
    Bradberry JC; Srnka Q
    Am J Manag Care; 1998 Dec; 4(12):1727-35; quiz 1736-7. PubMed ID: 10339105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.
    Skelton JB; ;
    J Am Pharm Assoc (2003); 2011; 51(6):704-12. PubMed ID: 22068191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third party reimbursement for pharmacist services: why has it been so difficult to obtain and is it really the answer for pharmacy?
    Ganther JM
    J Am Pharm Assoc (Wash); 2002; 42(6):875-9. PubMed ID: 12482013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financial analysis of cardiovascular wellness program provided to self-insured company from pharmaceutical care provider's perspective.
    Wilson JB; Osterhaus MC; Farris KB; Doucette WR; Currie JD; Bullock T; Kumbera P
    J Am Pharm Assoc (2003); 2005; 45(5):588-92. PubMed ID: 16295644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical care in community pharmacies: practice and research in the US.
    Christensen DB; Farris KB
    Ann Pharmacother; 2006; 40(7-8):1400-6. PubMed ID: 16868221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Have consultant pharmacists provided value to long-term care payers?
    Vogenberg FR; Dhir S
    Consult Pharm; 2006 Jan; 21(1):72-5. PubMed ID: 16524354
    [No Abstract]   [Full Text] [Related]  

  • 11. Reengineering the retail/ambulatory pharmacy for provision of biotechnology pharmaceutical services.
    Schneider PJ
    Pharm Pract Manag Q; 1998 Jul; 18(2):32-6. PubMed ID: 10185237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring in ambulatory care.
    Goode MA; Gums JG
    Ann Pharmacother; 1993 Apr; 27(4):502-5. PubMed ID: 8477129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of managed care on pharmacy practice.
    Schafermeyer KW
    Pharm Pract Manag Q; 2000 Jan; 19(4):99-116. PubMed ID: 10787569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A consistent professional brand for pharmacy-the need and a path forward.
    Speedie MK; Anderson LJ
    J Am Pharm Assoc (2003); 2017; 57(2):256-260. PubMed ID: 27964888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies.
    Pritchett J; McCrory G; Kraemer C; Jensen B; Allen LV
    Int J Pharm Compd; 2018; 22(1):7-16. PubMed ID: 29385381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.
    Kirschenbaum BE
    Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the route to medication therapy management documentation and billing standardization and interoperabilility within the health care system: meeting proceedings.
    Millonig MK
    J Am Pharm Assoc (2003); 2009; 49(3):372-82. PubMed ID: 19357067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
    Murry L; Gerleman B; Urick B; Urmie J
    J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers to pharmaceutical care in Argentina.
    Uema SA; Vega EM; Armando PD; Fontana D
    Pharm World Sci; 2008 Jun; 30(3):211-5. PubMed ID: 17978859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacist compensation for cognitive services: focus on the physician office and community pharmacy.
    Snella KA; Trewyn RR; Hansen LB; Bradberry JC
    Pharmacotherapy; 2004 Mar; 24(3):372-88. PubMed ID: 15040651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.